<DOC>
	<DOC>NCT01443403</DOC>
	<brief_summary>The purpose of this study is to determine efficacy and safety of S-297995 for the treatment of opioid-induced constipation in subjects with non-malignant chronic pain receiving opioid therapy for ≥3 months</brief_summary>
	<brief_title>A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>Subjects aged 18 years or older at time of informed consent with nonmalignant chronic pain experiencing opioidinduced constipation Subjects with &lt;3 spontaneous bowel movements a week and experiencing bowel symptoms Subjects receiving chronic opioid therapy due to nonmalignant pain for ≥3 months Evidence of clinically significant gastrointestinal disease History of chronic constipation prior to starting analgesic medication or any potential nonopioid cause of bowel dysfunction that may be a major contributor to the constipation Severe constipation that has not been appropriately managed such that the subject is at immediate risk of developing serious complications of constipation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Opioid Therapy</keyword>
	<keyword>Non-Malignant Chronic Pain</keyword>
	<keyword>Opioid-Induced Constipation</keyword>
</DOC>